Steve Zenker; Vice President of Investor Relations; Medifast Inc. Daniel Chard; Chairman of the Board, Chief Executive Officer; Medifast Inc. James Maloney; Chief Fi ...

Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

Q4 2024 Earnings Call Transcript February 18, 2025 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $-0.16. Operator: Greetings and welcome to the Medifast Fourth ...

Medifast has a 52-week low of $14.76 and a 52-week high of $52.96. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ratio of 0.06. The company’s 50-day simple ...

These products are featured in two new science-backed nutrition plans designed ... With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and gastric malaise. GLP-1 receptor targeting has been successful for weight loss ...

Researchers from across the country believe they have developed a breakthrough weight loss drug treatment: two new peptide compounds ... in the first four weeks, according to a May 2024 study ...

I'm sure Tyler will lose the race lead tomorrow, but later in the week I think he'll be contesting ... Johnny Sundt (Kelly Benefits Strategies-Medifast) decided to try and bridge up. For the next 20 ...

It’s a subjective measure, with no way to prove it. But the Islanders might be benefiting more from two weeks off than any other team in the NHL. With an injured list that includes Mat Barzal ...

Two Weeks in August, an original eight-part drama series from the makers of I May Destroy You and Such Brave Girls, will go into production soon This is a story about what it’s like to try and ...